Fundz

Who to call at Dr. Reddy's Laboratories, and when

Fundz watches for the moments Dr. Reddy's Laboratories starts buying, and tells you who to reach.

  • An alert the day Dr. Reddy's Laboratories raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dr. Reddy's Laboratories, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dr. Reddy's Laboratories. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Dr Reddy’s Laboratories partners with Takeda Biopharmaceuticals for exclusive distribution of Qdenga vaccine in India.

Sep 18, 2026

Contract Type

partnership

HyderabadManufacturingBiotechnologyHealth CareTravelEmployee BenefitsPharmaceuticalInsurtechInsurancepharmaceuticals

Description

Dr Reddy’s Laboratories has entered into an exclusive marketing agreement with Takeda Biopharmaceuticals to distribute Qdenga, a dengue vaccine, in India’s private healthcare sector. This partnership aims to strengthen Dr Reddy’s presence in the vaccine market and address the growing dengue burden in the country.

Company Information

Company

Dr. Reddy's Laboratories

Location

8-2-268/4 Road Number 3

Hyderabad, Telangana, India

About

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, India, specializing in the development, manufacturing, and marketing of a wide range of pharmaceuticals.

Related People

Milan
Likely contact at this company
••••••••@••••••••

See Milan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Dr. Reddy's Laboratories's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Dr. Reddy's Laboratories signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.